Roux-en-Y Gastric Bypass Compared to Glucagon-Like Peptide-1 Receptor Agonists is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity: A Matched Analysis Over Two Years.
Saved in:
| Title: | Roux-en-Y Gastric Bypass Compared to Glucagon-Like Peptide-1 Receptor Agonists is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity: A Matched Analysis Over Two Years. |
|---|---|
| Authors: | Thiyagarajan S; Division of Advanced GI and Bariatric Surgery, Mayo Clinic, Jacksonville, FL, USA., Wall-Wieler E; Global Health Economics and Outcomes Research, Intuitive Surgical (United States), Sunnyvale, CA, USA., Liu Y; Global Health Economics and Outcomes Research, Intuitive Surgical (United States), Sunnyvale, CA, USA., Zheng F; Global Health Economics and Outcomes Research, Intuitive Surgical (United States), Sunnyvale, CA, USA.; DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Edwards M; Division of Advanced GI and Bariatric Surgery, Mayo Clinic, Jacksonville, FL, USA. maeedw@gmail.com. |
| Source: | Obesity surgery [Obes Surg] 2026 Feb; Vol. 36 (2), pp. 376-385. Date of Electronic Publication: 2026 Jan 03. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9106714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1708-0428 (Electronic) Linking ISSN: 09608923 NLM ISO Abbreviation: Obes Surg Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
